Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0001415889-25-019380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | PMVP | Mack David Henry | Pres, CEO, Dir | S - Sale | $1.06 | -58.4K | 536.1K | -10% | -$61.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 58,411 | $1.06 | 536,133 | D | — | — | (F1) The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. (F2) Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. |